Pediatric Mitochondrial Disease: Clinical and Genetic Insights From a Single-Center Cohort
Abstract
Background: Mitochondrial diseases are a heterogeneous group of inherited metabolic disorders characterized by dysfunction in oxidative phosphorylation, leading to impaired cellular energy metabolism. These disorders present with a broad clinical spectrum, often involving the nervous system, muscles, heart, and liver, making diagnosis complex.
Methods: This retrospective study evaluates the clinical, laboratory, and genetic characteristics of 19 pediatric patients diagnosed with mitochondrial diseases at the pediatric metabolism clinic.
Results: The most common clinical findings were hypotonia (52.6%), lactic acidosis (26.3%), and seizures (21.1%), followed by neuromotor delay (10.5%) and bilateral optic atrophy (10.5%). These findings reflect the multisystemic involvement and neurological predominance typical of mitochondrial disorders. Biochemical analyses frequently revealed abnormal metabolic profiles supportive of mitochondrial dysfunction.
Conclusions: Genetic analyses identified various mitochondrial DNA and nuclear DNA mutations, underscoring the importance of comprehensive molecular diagnostics. Molecular testing improved diagnostic accuracy and facilitated more tailored patient management, including early initiation of supportive treatments and genetic counselling.
Keywords
Kaynakça
- Rahman S. Mitochondrial diseases and status epilepticus. Epilepsia. 2018;59:70-7.
- Schirrmacher V. Mitochria at work: new insights into regulation and dysregulation of cellular energy supply and metabolism. Biomedicines. 2020;8(11):526.
- Bergman O, Ben-Shachar D. Mitochondrial oxidative phosphorylation system (OXPHOS) deficits in schizophrenia: possible interactions with cellular processes. Can J Psychiatry. 2016;61(8):457-69.
- Zhu Z, Wang X. Significance of mitochondria DNA mutations in diseases. In: Mitochondrial DNA and diseases. 2017. p. 219-30.
- Gusic M, Prokisch H. Genetic basis of mitochondrial diseases. FEBS Lett. 2021;595(8):1132-58.
- Schon KR, Ratnaike T, van den Ameele J, Horvath R, Chinnery PF. Mitochondrial diseases: a diagnostic revolution. Trends Genet. 2020;36(9):702-17.
- Schlieben LD, Prokisch H. The dimensions of primary mitochondrial disorders. Front Cell Dev Biol. 2020;8:600079.
- Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015;17(9):689-701.
- Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, et al. Mitochondrial diseases. Nat Rev Dis Primers. 2016;2(1):16080.
- Barrientos A, Fontanesi F, Díaz F. Evaluation of the mitochondrial respiratory chain and oxidative phosphorylation system using polarography and spectrophotometric enzyme assays. Curr Protoc Hum Genet. 2009;63(1):19.3.1-19.3.4.